Immunology
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
Antibody-dependent enhancement
| 32504046 2020. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures. |
| 32092539 2020. Is COVID-19 receiving ADE from other coronaviruses? |
32268188 ä. It is too soon to attribute ADE to COVID-19
| 31826992 2020. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry |
| 32317716 ä. The potential danger of suboptimal antibody responses in COVID-19 |
32346094 ä. COVID-19 vaccine design: the Janus face of immune enhancement
32303697 ä. Will we see protection or reinfection in COVID-19?
32438257 2020. SARS-CoV-2 and enhancing antibodies
| 32408068 2020. What about the original antigenic sin of the humans versus SARS-CoV-2? |
32436320 2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
32506725 2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.
Herd immunity
32438622 2020. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.
32391855 2020. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
32510562 2020. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
32418947 2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?
32372779 2020. Do you become immune once you have been infected?
Neutralizing antibodies
32454513 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection.
32454512 2020. A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.
32497196 2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.
| 32073157 2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |
Innate sensing
| 32291557 ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells |
32198201 2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
32374430 2020. DC/L-SIGNs of Hope in the COVID-19 Pandemic
32361001 ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
32248387 ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
| 32407669 ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients |
32456409 2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.
| 32156572 2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation |
integrative work
32205856 2020. COVID-19 infection: the perspectives on immune responses
32359396 ä. A Dynamic Immune Response Shapes COVID-19 Progression
C7064018 ä. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses
| C7200337 ä. Immunology of COVID-19: current state of the science |
32505227 2020. Immunology of COVID-19: Current State of the Science.
32469225 2020. COVID-19 and the immune system.
| 32436629 2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis. |
32507543 2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.
| 32504757 2020. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications. |
32493812 2020. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
32470151 2020. The perplexing question of trained immunity versus adaptive memory in COVID-19.
32472706 2020. The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.
32213336 ä. SARS-CoV-2: virus dynamics and host response
covid modulates the immune system
32364527 2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
32172672 2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
32315725 ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China
| 32355328 ä. Impaired interferon signature in severe COVID-19 |
32375560 2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study
32376308 ä. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
| 32236983 2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection |
| 32286536 ä. Coronaviruses hijack the complement system |
32463803 2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
32492165 2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
immune cell subpopulations
32282871 ä. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19)
32325421 2020. Increased expression of CD8 marker on T-cells in COVID-19 patients
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32346099 ä. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients
32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
32228226 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
32196410 2020. Hypothesis for potential pathogenesis of SARS-CoV-2 infection?a review of immune changes in patients with viral pneumonia
32333914 ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia
32344320 ä. The clinical course and its correlated immune status in COVID-19 pneumonia
32325129 ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia
32283159 ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
32227123 ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
32343510 2020. COVID-19: are T lymphocytes simply watching?
32379887 ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19
32297671 2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
32352397 2020. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
32379199 2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes
32296069 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
32407057 2020. Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series.
32297828 2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
32370466 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32114745 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
| 32376308 2020. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis |
32458561 2020. Lymphopenia in COVID-19: Therapeutic opportunities.
32420610 2020. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
32470153 2020. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
32474608 2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.
t cell exhaustion
32249845 ä. Fighting COVID-19 exhausts T cells
| 32203188 ä. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |
| 32203186 ä. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |
| 32203188 2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |
| 32203186 2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |
nk cells
32382127 ä. NKG2A and COVID-19: another brick in the wall
32344314 2020. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents
plasmacytoid dendritic cells
32298486 2020. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19)
antiviral immune response
32280952 ä. Good IgA bad IgG in SARS-CoV-2 infection?
32353870 2020. The many faces of the anti-COVID immune response
32358956 ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19
31981224 2020. Coronavirus infections and immune responses
32198005 2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic
32284614 ä. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
32355329 ä. SARS-CoV-2-reactive T cells in patients and healthy donors
32346091 ä. Neutralizing antibody response in mild COVID-19
32356908 2020. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis
| 32343415 2020. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients |
32330332 2020. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic
32267987 2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS
32348715 2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020
32382126 ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients
32200654 2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
32476607 2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.
32449333 2020. (+)Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.
32430094 2020. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
32467617 2020. Serum IgA, IgM, and IgG responses in COVID-19.
| 32467616 2020. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells. |
| 32463434 2020. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling. |
mediators
32360285 ä. Type I IFN immunoprofiling in COVID-19 patients
| 32376393 ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |
| 32305501 ä. The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement |
30715745 2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study
32414693 2020. Interleukin-6 levels in children developing SARS-CoV-2 infection
| 32421281 2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4? |
32437622 2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.
immunopathology
32371101 ä. The correlation between SARS-CoV-2 infection and rheumatic disease
32205186 2020. COVID-19 infection and rheumatoid arthritis: Faraway, so close!
32308263 2020. CoViD-19 Immunopathology and Immunotherapy
32320677 ä. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32282863 ä. Molecular immune pathogenesis and diagnosis of COVID-19
32321823 2020. COVID-19: an Immunopathological View
32273594 ä. COVID-19: immunopathology and its implications for therapy
32303696 ä. Macrophages: a Trojan horse in COVID-19?
| 32376901 ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages |
32423059 2020. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.
32485101 2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
32423917 2020. COVID-19 as an Acute Inflammatory Disease.
| 32512289 2020. Neutralizing antibodies mediate virus-immune pathology of COVID-19. |
32398875 2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.
32391668 2020. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].
| 32498376 2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19. |
32460357 2020. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.
secondary autoimmunity
32292901 2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity
32220633 2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
32315487 2020. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19
| 32314313 2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? |
32389543 ä. COVID-19 and molecular mimicry: The Columbus? egg?
32444414 2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.
Thymus
32340873 ä. Reply: Thymopoiesis, inflamm-aging, and COVID-19 phenotype
32317217 ä. Role of thymopoiesis and inflamm-aging in COVID-19 phenotype
Eosinopenia, Eosinophilia
32368728 ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study
32344056 ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination
32369190 2020. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series
| 32315429 ä. Eosinophil count in severe coronavirus disease 2019 (COVID-19) |
32315421 ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)
32390402 2020. SARS-CoV-2 and Eosinophilia.
microbiome
32497191 2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.
| 32426999 2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity. |
008
32525657 2020. Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia.
32463221 2020. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients.
32503680 2020. Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.
32503668 2020. Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.
32412156 2020. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.
32398307 2020. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
32379368 2020. Gastrointestinal effects of an attempt to "disinfect" from COVID-19.
32398162 2020. COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission.
32498696 2020. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice.
32461409 2020. Sanitizer aerosol-driven ocular surface disease (SADOSD)-A COVID-19 repercussion?
32519263 2020. India's COVID-19 Testing Strategy: Why Pediatric Hospitals Need to Focus More on ILI than SARI?
32277747 2020. A Low-cost Solution for Retro-fitment of HEPA Filter in Healthcare Facilities Providing Care to COVID-19 Patients.
32381129 2020. Dealing with skin reactions to gloves during the COVID-19 pandemic.
32456749 2020. Filtration evaluation and clinical use of expired elastomeric P-100 filter cartridges during the COVID-19 pandemic.
32408923 2020. Facepiece filtering respirators with exhalation valve should not be used in the community to limit SARS-CoV-2 diffusion.
32459123 2020. Mechanistic inferences from clinical reports of SARS-CoV-2.
32474804 2020. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
32468178 2020. Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
32399895 2020. Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
32492530 2020. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity.
32470604 2020. A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response.
32464271 2020. Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
32425643 2020. Association of inflammatory markers with the severity of COVID-19: A meta-analysis.
32425634 2020. The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection.
32422376 2020. Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe Coronavirus disease 2019: A case report.
32437933 2020. Viral dynamics in asymptomatic patients with COVID-19.
32437934 2020. Use of anakinra in severe COVID-19: a case report.
32497811 2020. Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
32497810 2020. HUMAN CORONAVIRUS DATA FROM FOUR CLINICAL TRIALS OF MASKS AND RESPIRATORS.
32504146 2020. Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation.
32500199 2020. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.
32458044 2020. Inside the lungs of COVID-19 disease.
32397684 2020. SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
32397010 2020. N95 respirator associated pressure ulcer amongst COVID-19 health care workers.
32396265 2020. The prevalence, characteristics, and related factors of pressure injury in medical staff wearing personal protective equipment against COVID-19 in China: A multicentre cross-sectional survey.
32385523 2020. IL-6 may be a good biomarker for earlier detection of COVID-19 progression.
32424481 2020. Stages or phenotypes? A critical look at COVID-19 pathophysiology.
32424480 2020. Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of microthrombi in a COVID-19 patient.
32514592 2020. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.
32504103 2020. Ten things we learned about COVID-19.
32494929 2020. COVID-19: 10 things I wished I'd known some months ago.
32494927 2020. Histological-ultrasonographical correlation of pulmonary involvement in severe COVID-19.
32488341 2020. Rethinking the respiratory paradigm of COVID-19: a 'hole' in the argument.
32533198 2020. Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection.
32430651 2020. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
32415560 2020. Bronchoalveolar lavage findings in severe COVID-19 pneumonia.
32399954 2020. SARS-CoV-2 and myocardial injury: a role for Nox2?
32405622 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
32389590 2020. COVID-19: Unanswered questions on immune response and pathogenesis.
32425269 2020. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19.
32422146 2020. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
32422144 2020. Perforin and resistance to SARS coronavirus 2.
32417135 2020. Complement activation in patients with COVID-19: A novel therapeutic target.
32413374 2020. Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective.
32437740 2020. The immunologic status of newborns born to SARS-CoV-2-infected mothers in Wuhan, China.
32407836 2020. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.
32531372 2020. Expression of SARS-CoV-2 Receptor ACE2 and Coincident Host Response Signature Varies by Asthma Inflammatory Phenotype.
32416206 2020. COVID-19 and personal protective equipment: Treatment and prevention of skin conditions related to the occupational use of personal protective equipment.
32417418 2020. Reply to: "Skin damage among health care workers managing coronavirus disease 2019".
32498686 2020. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
32515358 2020. Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility.
32458400 2020. Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19.
32406037 2020. COVID-19: is fibrosis the killer?
32473501 2020. Respirators used by healthcare workers due to the COVID-19 outbreak increase end-tidal carbon dioxide and fractional inspired carbon dioxide pressure.
32510470 2020. Is innate immunity our best weapon for flattening the curve?
32430154 2020. Hypolipidemia is associated with the severity of COVID-19.
32434770 2020. Predictive molecular pathology in the time of COVID-19.
32283335 2020. ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease.
32361326 2020. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.
32464309 2020. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients.
32425659 2020. Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design.
32451971 2020. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?
32398780 2020. The role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection.
32456973 2020. The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children.
32366279 2020. Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.
32437830 2020. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
32385146 2020. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
32442454 2020. Which cancer type has the highest risk of COVID-19 infection?
32417316 2020. Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19.
32417310 2020. Characterization of eight novel full-length genomes of SARS-CoV-2 among imported COVID-19 cases from abroad in Yunnan, China.
32526326 2020. Interleukin-6 as prognosticator in patients with COVID-19.
32525000 2020. Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19.
32534002 2020. Cancer population may be paradoxically protected from severe manifestations of COVID-19.
32283152 2020. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
32283146 2020. Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy.
32360499 2020. Comparative seasonalities of influenza A, B and 'common cold' coronaviruses - setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions.
32283147 2020. Prolonged virus shedding even after seroconversion in a patient with COVID-19.
32534944 2020. Influence of NAD+ as an ageing-related immunomodulator on COVID 19 infection: A hypothesis.
32483488 2020. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis.
32454066 2020. High expression of ACE2 on the keratinocytes reveals skin as a potential target for SARS-CoV-2.
32461703 2020. Mechanobiology predicts raft formations triggered by ligand-receptor activity across the cell membrane.
32383269 2020. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
32383254 2020. Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples.
32383183 2020. A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex.
32410229 2020. Evidence of Increasing Diversification of Emerging SARS-CoV-2 Strains.
32406952 2020. Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity.
32401345 2020. Genetic variants and source of introduction of SARS-CoV-2 in South America.
32181903 2020. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.
32159234 2020. Identification of coronavirus sequences in carp cDNA from Wuhan, China.
32519779 2020. Circulating levels of IL-2, IL-4, TNF-alpha, IFN-gamma, and C-reactive protein are not associated with severity of COVID-19 symptoms.
32242950 2020. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
32471659 2020. Silencing of immune activation with methotrexate in patients with COVID-19.
32534807 2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.
32452979 2020. Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab.
32392072 2020. Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks.
32463239 2020. Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atom Simulations.
32521376 2020. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.
32514817 2020. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
32525700 2020. Multi-System Inflammatory Syndrome in Children in Association with COVID-19.
32521002 2020. Antibody profiles in mild and severe cases of COVID-19.
32522846 2020. ACE2 and COVID-19 and the resulting ARDS.
32522874 2020. Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.
32479986 2020. Type 3 hypersensitivity in COVID-19 vasculitis.
32479985 2020. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
32473354 2020. Racial disparity in Covid-19 mortality rates - A plausible explanation.
32474885 2020. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
32462425 2020. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.
32399213 2020. Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.
32384917 2020. COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.
32456696 2020. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients.
32456658 2020. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis.
32414395 2020. COVID-19: room for treating T cell exhaustion?
32410690 2020. Age and sex differences in soluble ACE2 may give insights for COVID-19.
32517773 2020. Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19.
32499988 2020. Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines.
32416074 2020. A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein.
32460144 2020. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions.
32522400 2020. Letter to the Editor on "Bonafe M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev".
32513566 2020. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
32475759 2020. IL-6: Relevance for immunopathology of SARS-CoV-2.
32446778 2020. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
32389499 2020. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes.
32421092 2020. SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc.
32470851 2020. Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis.
32417709 2020. Mechanism of inflammatory response in associated comorbidities in COVID-19.
32517769 2020. Histopathology of COVID-19 pneumonia in two non-oncological, non-hospitalised cases as a reliable diagnostic benchmark.
32412125 2020. Androgen sensitivity gateway to COVID-19 disease severity.
32454408 2020. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.
32393438 2020. Intelligent classification of platelet aggregates by agonist type.
32529906 2020. Serological differentiation between COVID-19 and SARS infections.
32529952 2020. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
32525765 2020. Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries.
32515685 2020. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.
32515684 2020. Patterns of IgG and IgM antibody response in COVID-19 patients.
32380903 2020. Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2.
32533508 2020. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19.
32419876 2020. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictive, preventive, and personalized medical approach.
32444797 2020. BBMRI-ERIC's contributions to research and knowledge exchange on COVID-19.
32415272 2020. Connecting data, tools and people across Europe: ELIXIR's response to the COVID-19 pandemic.
32404885 2020. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
32376989 2020. The VODAN IN: support of a FAIR-based infrastructure for COVID-19.
32335973 2020. Of mice and men: COVID-19 challenges translational neuroscience.
32444400 2020. COVID-19 and the nicotinic cholinergic system.
32398299 2020. To compare the incomparable: COVID-19 pneumonia and high altitude disease.
32432790 2020. Editorial - COVID-19 and the microbiota: new kids on the block.
32432787 2020. SARS-CoV-2 identification in lungs, heart and kidney specimens by transmission and scanning electron microscopy.
32524957 2020. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020.
32524946 2020. Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020.
32474064 2020. A novel cell-based assay for dynamically detecting neutrophil extracellular traps-induced lung epithelial injuries.
32454103 2020. Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection.
32489244 2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge Von Willebrand Factor (eULVWF) Decorated-Platelet Strings.
32399755 2020. A technical report from the Italian SARS-CoV-2 outbreak. Postmortem sampling and autopsy investigation in cases of suspected or probable COVID-19.
32425955 2020. Potential SARS-CoV-2 Preimmune IgM Epitopes.
32425950 2020. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).
32391299 2020. COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children.
32442562 2020. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
32413354 2020. Age, inflammation and disease location are critical determinants of intestinal expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in inflammatory bowel disease.
32437749 2020. Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.
32445924 2020. Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution.
32510005 2020. COVID-19 target: A specific target for novel coronavirus detection.
32526937 2020. Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak.
32520981 2020. ACE2 diversity in placental mammals reveals the evolutionary strategy of SARS-CoV-2.
32504168 2020. Impact of glycoscience in fighting Covid-19.
32522249 2020. Genomics of COVID-19: molecular mechanisms going from susceptibility to severity of the disease.
32437706 2020. Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report.
32483525 2020. A fatal case of COVID-19 due to metabolic acidosis following dysregulate inflammatory response (cytokine storm).
32433946 2020. Herd Immunity: Understanding COVID-19.
32392464 2020. SARS-CoV-2: Combating Coronavirus Emergence.
32497522 2020. Respiratory Virus Infections: Understanding COVID-19.
32413330 2020. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
32534867 2020. Sequence homology between human PARP14 and the SARS-CoV-2 ADP ribose 1'-phosphatase.
32524333 2020. COVID 19: a clue from innate immunity.
32473952 2020. SARS-CoV-2: The viral shedding vs infectivity dilemma.
32509257 2020. SARS-CoV-2, "common cold" coronaviruses' cross-reactivity and "herd immunity": The razor of Ockham (1285-1347)?
32474891 2020. COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia.
32473977 2020. Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.
32473976 2020. SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective.
32473352 2020. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
32450246 2020. Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience.
32405281 2020. Sars-CoV-2 and black population: ACE2 as shield or blade?
32502733 2020. Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach.
32524515 2020. Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.
32532942 2020. MERS-CoV and SARS-CoV infections in animals: a systematic review and meta-analysis of prevalence studies.
32529477 2020. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
32501423 2020. Developing an ultra-efficient microsatellite discoverer to find structural differences between SARS-CoV-1 and Covid-19.
32531713 2020. Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19.
32437920 2020. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line.
32534186 2020. Procalcitonin levels in COVID-19 patients.
32485251 2020. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.
32516845 2020. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19.
32530491 2020. Presepsin as a predictive biomarker of severity in COVID-19: A case series.
32519791 2020. Hypoalbuminaemia in COVID-19 infection: A predictor of severity or a potential therapeutic target?
32519786 2020. Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection.
32519768 2020. Hyperpyrexia in COVID-19 patients.
32526083 2020. Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19.
32530583 2020. Neuropathological Features of Covid-19.
32534467 2020. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
32515386 2020. Glucovigilance in COVID-19.
32515374 2020. The Microbiology of Coronaviruses.
31896597 2020. Host AAA+ ATPase TER94 Plays Critical Roles in Building the Baculovirus Viral Replication Factory and Virion Morphogenesis.
32518411 2020. Genomic search for COVID-19 severity clues.
32514174 2020. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
32528156 2020. Ten recommendations for supporting open pathogen genomic analysis in public health.
32528149 2020. Kawasaki disease in a COVID-19-struck region.
32427517 2020. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.
32533838 2020. The pathological autopsy of coronavirus disease 2019 (COVID-2019) in China: a review.
32527802 2020. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.
32467368 2020. Doctors race to understand inflammatory condition in kids.
32467367 2020. Scientists put survivors' blood plasma to the test.
32439770 2020. T cells found in coronavirus patients 'bode well' for long-term immunity.
32527928 2020. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.
32527925 2020. Type III interferons disrupt the lung epithelial barrier upon viral recognition.
32526773 2020. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.
32513613 2020. COVID-19 and the ABO blood group connection.
007
some other papers
32496715 2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]
32455617 2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.
32512133 2020. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.
32512089 2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.
32470223 2020. COVID-19: Structural Predictions of Viral Success.
32423901 2020. How covid-19 is accelerating the threat of antimicrobial resistance.
32413176 2020. The emergence of methemoglobinemia amidst the COVID-19 pandemic.
32504123 2020. COVID-19 research: toxicological input urgently needed!
32412787 2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.
32213337 ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32360743 ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19
32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan
32346093 ä. The trinity of COVID-19: immunity, inflammation and intervention
32348636 2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva
32235915 ä. COVID-19: a new challenge for human beings
| 32359201 2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures |
32376309 2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
32132669 ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
32388390 2020. The powerful immune system against powerful COVID-19: A hypothesis
32372807 2020. The fever paradox
32449057 2020. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.
32220035 2020. SARS-CoV-2: What do we know so far?
32534452 2020. From causes of aging to death from COVID-19.
32339157 2020. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.
32489708 2020. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19).
32489698 2020. COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile.
32401346 2020. SARS-CoV-2 immunogenicity at the crossroads.
32396996 2020. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
32053148 2020. Three Emerging Coronaviruses in Two Decades.
32475764 2020. An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients.
32513452 2020. Abdominal pain in a patient with COVID-19 infection: A case of multiple thromboemboli.
32471782 2020. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department.
32471783 2020. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19.
32425320 2020. Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.
32532619 2020. Toxic shock-like syndrome and COVID-19: A case report of multisystem inflammatory syndrome in children (MIS-C).
32405074 2020. Visualization of SARS-CoV-2 virus invading the human placenta using electron microscopy.
32533928 2020. Letter-to-the-Editor: Alternative Interpretation to the Findings Reported in Visualization of SARS-CoV-2 Virus Invading the Human Placenta Using Electron Microscopy.
32391518 2020. Detection of SARS-COV-2 in Placental and Fetal Membrane Samples.
32427221 2020. Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth.
32471774 2020. SARS-CoV-2: Naso-bronchial cytological correlations.
32516444 2020. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.
32439309 2020. Revision narrativa sobre la respuesta inmunitaria frente a coronavirus: descripcion general, aplicabilidad para SARS-COV-2 e implicaciones terapeuticas.
32505756 2020. Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.
32505755 2020. Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
32526061 2020. Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection.
32502135 2020. Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.
32458111 2020. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients.
32414383 2020. Plasma CRP level is positively associated with the severity of COVID-19.
32387855 2020. Analysis of complement deposition and viral RNA in placentas of COVID-19 patients.
32462329 2020. Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19.
32500224 2020. Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report.
32495027 2020. Hematological findings in coronavirus disease 2019: indications of progression of disease.
32529285 2020. SARS-CoV-2 infection in children with febrile neutropenia.
32529284 2020. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
32382776 2020. Signals of Th2 immune response from COVID-19 patients requiring intensive care.
32436075 2020. Microvascular alterations in patients with SARS-COV-2 severe pneumonia.
32488505 2020. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children.
32422085 2020. Cytokine Levels in the Body Fluids of a Patient With COVID-19 and Acute Respiratory Distress Syndrome: A Case Report.
32527868 2020. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
32395525 2020. A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection.
32405117 2020. Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
32532524 2020. SARS-CoV-2-A Tough Opponent for the Immune System.
32493627 2020. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.
32471702 2020. Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?
32471703 2020. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room.
32419712 2020. COVID-19 and Dysfunctional Endothelium: The Mexican Scenario.
32535095 2020. Molecular mimicry may explain multi-organ damage in COVID-19.
32535093 2020. Covid-19 and autoimmunity.
32410735 2020. Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.
32485205 2020. The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.
32479856 2020. SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention.
32480226 2020. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections.
32425294 2020. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
32407552 2020. Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID-19 patient.
32529634 2020. Haemophagocytosis in bone marrow aspirates in patients with COVID-19.
32526046 2020. Secondary HLH is uncommon in severe COVID-19.
32446945 2020. Do matrix metalloproteases mediate the SARS-CoV-2-related damage to the central nervous system?
32454136 2020. The role of IgA in COVID-19.
32512702 2020. COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.
32479746 2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
32492406 2020. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
32416070 2020. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
32413319 2020. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
32526206 2020. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
32526208 2020. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
32516571 2020. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
32473127 2020. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
32425270 2020. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells.
32405102 2020. A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.
32514047 2020. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
32513989 2020. The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.
32499922 2020. ACE2 expression and sex disparity in COVID-19.
32485164 2020. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.
32464098 2020. The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?
32415260 2020. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
32398804 2020. Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?
32426212 2020. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
32531208 2020. Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2.
32458383 2020. On barring the vascular gateway against severe COVID-19 disease.
32500379 2020. COVID-19 and heme oxygenase: novel insight into the disease and potential therapies.
32454047 2020. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19.
32417210 2020. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
32405080 2020. Decreased T cell populations contribute to the increased severity of COVID-19.
32531257 2020. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.
32531256 2020. Cytokine Storm Induced by SARS-CoV-2.
32461193 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
32526273 2020. A plea for the pathogenic role of immune complexes in severe Covid-19.
32407466 2020. An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.
32454188 2020. Correlation between viral RNA shedding and serum antibodies in individuals with coronavirus disease 2019.
32447048 2020. SARS-CoV-2 persisted in lung tissue despite disappearance in other clinical samples.
32526483 2020. COVID 19 and brain crosstalks.
32525600 2020. Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes.
32535877 2020. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).
32533690 2020. Placental Pathology in COVID-19.
32432897 2020. Reply: COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency.
32432896 2020. Respiratory Mechanics and Gas Exchange in COVID-19 Associated Respiratory Failure.
32432895 2020. COVID-19 Lung Injury and "Typical" ARDS: The Danger of Presumed Equivalency.
32434816 2020. Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?
32524832 2020. Is Albumin Predictor of Mortality in COVID-19?
32531085 2020. C1-INH and the contact system in COVID-19.
32533986 2020. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.
32526272 2020. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.
32533824 2020. Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19.
32517505 2020. C3 polymorphisms represent an important immunological confounder on the spread and outcome of COVID-19.
32518941 2020. Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics.
32522666 2020. How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?
32526370 2020. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
32525565 2020. Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients.
32425712 2020. Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.
32535977 2020. Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome.
32513850 2020. Early Insights into Immune Responses during COVID-19.
32526012 2020. ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19.
32515982 2020. H2S as a potential defence against COVID-19?
32526026 2020. Hypersegmented granulocytes and COVID-19 infection.
